NCT05689333 is a NA clinical trial of Vista Vitrectomy Probe in Vitrectomy, sponsored by VISTA Ophthalmics.

Who is sponsoring NCT05689333?

NCT05689333 is sponsored by VISTA Ophthalmics.

What drugs are being tested in NCT05689333?

Interventions in NCT05689333: Vista Vitrectomy Probe.

What condition does NCT05689333 study?

NCT05689333 studies Vitrectomy.

Is NCT05689333 still recruiting?

NCT05689333 is currently completed. Last updated 1 April 2025.

Last reviewed 2025-04-01 · How we verify

NCT05689333

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study to Evaluate the Safety and Performance of the Vista Probe for Vitrectomy Surgery

Completed NA Last updated 1 April 2025

What this trial tests

NA trial testing Vista Vitrectomy Probe in Vitrectomy in 32 participants. Completed in 7 May 2024.

Timeline

9 December 2022

Primary endpoint
7 May 2024

7 May 2024

Quick facts

Lead sponsor	VISTA Ophthalmics
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	32
Start date	9 December 2022
Primary completion	7 May 2024
Estimated completion	7 May 2024
Sites	4 locations across United States

Drugs / interventions tested

Vista Vitrectomy Probe

Conditions studied

Vitrectomy — all drugs for Vitrectomy →

Sponsor

VISTA Ophthalmics

Who can join

18 and older, any sex, with Vitrectomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, single-arm, non-comparative, open-label, monocular, post approval study to assess safety and device performance of the Vista Vitrectomy Probe during vitrectomy surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05689333 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by VISTA Ophthalmics
Last refreshed: 1 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05689333.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing